SYS ONLINE

Andrographis (KalmCold)

Standardized andrographolide for acute upper respiratory infections.

Overview

Standardized andrographolide for acute upper respiratory infections.

Natural sources
    Common forms

      Forms & variants of Andrographis

      Different chemical forms of Andrographis behave differently. Browse each form's mechanism, bioavailability, and best-use context.

      Mechanism of action

      Modulates NF-κB, cytokine release, and immune cell trafficking.

      Pathways

        Effects on the body

        Organ system effects

        Evidence-based benefits

        Shortens URI duration

        Strong evidence

        Potential side effects

        Common
        • · GI upset
        • · Skin rash
        Rare
        • · Hepatotoxicity (chronic high dose)
        Serious

          Drug interactions

          Anticoagulants
          Antiplatelet effect.
          moderate
          Immunosuppressants
          Antagonism.
          moderate

          Safety & non-supplemental interactions

          Educational summary — always confirm with your clinician or pharmacist before starting, stopping, or combining with prescription therapy.

          Avoid if you are
          • ·Pregnant or breastfeeding (insufficient safety data)
          • ·Children under 18 (unless directed by a clinician)
          Avoid with these conditions
          • ·Autoimmune disease (theoretical immune activation)
          Avoid / monitor with these medications
          • ·Immunosuppressants

          Supplement interactions

          Pairs well with

          None listed.

          Avoid combining with

          No specific avoidances listed.

          Dosing & bioavailability

          Typical dose
          200 mg KalmCold
          With food?
          With food

          Where to buy

          Affiliate-style search links to reputable retailers. We don't endorse specific brands — verify third-party testing (USP, NSF, Informed Sport) before purchase.

          Scientific evidence (8)

          RCTPhytomedicine · 2010

          KalmCold for URI

          Saxena RC, et al.

          5-day DB-RCT in 223 URI patients.

          Key findings

          Significant symptom improvement vs placebo by day 3.

          Open study
          Systematic reviewPubMed (NLM) · 1970

          PubMed: Andrographis (KalmCold) — Shortens URI duration

          Live PubMed search

          Live results for "Andrographis (KalmCold) Shortens URI duration" across the PubMed/MEDLINE peer-reviewed index.

          Key findings

          Opens current human and preclinical literature matching Andrographis (KalmCold) and "Shortens URI duration". Filter by RCT, meta-analysis, or year on the results page.

          Open study
          Systematic reviewPubMed (NLM) · 1970

          PubMed: Andrographis (KalmCold) — randomized controlled trial

          Live PubMed search

          Live results for "Andrographis (KalmCold) randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

          Key findings

          Opens current human and preclinical literature matching Andrographis (KalmCold) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

          Open study
          Systematic reviewPubMed (NLM) · 1970

          PubMed: Andrographis (KalmCold) — meta-analysis

          Live PubMed search

          Live results for "Andrographis (KalmCold) meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

          Key findings

          Opens current human and preclinical literature matching Andrographis (KalmCold) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

          Open study
          Systematic reviewPubMed (NLM) · 1970

          PubMed: Andrographis (KalmCold) — pharmacokinetics

          Live PubMed search

          Live results for "Andrographis (KalmCold) pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

          Key findings

          Opens current human and preclinical literature matching Andrographis (KalmCold) and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

          Open study
          Systematic reviewPubMed (NLM) · 1970

          PubMed: Andrographis (KalmCold) — safety adverse events

          Live PubMed search

          Live results for "Andrographis (KalmCold) safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

          Key findings

          Opens current human and preclinical literature matching Andrographis (KalmCold) and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

          Open study
          Systematic reviewPubMed (NLM) · 1970

          PubMed: Andrographis (KalmCold) — dose response

          Live PubMed search

          Live results for "Andrographis (KalmCold) dose response" across the PubMed/MEDLINE peer-reviewed index.

          Key findings

          Opens current human and preclinical literature matching Andrographis (KalmCold) and "dose response". Filter by RCT, meta-analysis, or year on the results page.

          Open study
          Systematic reviewGoogle Scholar · 1970

          Google Scholar: Andrographis (KalmCold) — clinical evidence

          Live Scholar search

          Cross-database citation index for Andrographis (KalmCold) as it relates to "clinical evidence".

          Key findings

          Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

          Open study
          Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.